Bm Bm12 Drops Liquid
NDC Package 85816-2012-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Bm Bm12 Drops (abies nigra, anti crud, condurango, lycopodium, nux vom, ornithogalum, symphytum) liquids is indications: For detail please read the enclosed package (Product information leaflet). This formulation utilizes a liquid delivery system. Marketed by Bm Private Limited, this product is identified by NDC 85816-2012.

Identification & Billing

NDC Package Code
85816-2012-2
Package Description
500 mL in 1 JAR
Product Code
85816-2012
11-Digit Billing Format
85816201202

Clinical Specifications

Proprietary Name
Bm Bm12 Drops
Non-Proprietary Name
Abies Nigra, Anti Crud, Condurango, Lycopodium, Nux Vom, Ornithogalum, Symphytum
Substance Name
Antimony Trisulfide; Comfrey Root; Lycopodium Clavatum Spore; Ornithogalum Umbellatum Whole; Picea Mariana Resin; Ruehssia Cundurango Bark; Strychnos Nux-vomica Seed
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Indications: For detail please read the enclosed package (Product information leaflet).

Regulatory & Marketing

Labeler Name
Bm Private Limited
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
01-01-2015
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (85816-2012). Click a package code to view its specific billing and regulatory data.

85816-2012-1
30 mL in 1 BOTTLE, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85816-2012-2 identifies a specific commercial package of 500 ml in 1 jar of Bm Bm12 Drops, a human over the counter drug labeled by Bm Private Limited. This liquid is formulated for oral use and contains antimony trisulfide; comfrey root; lycopodium clavatum spore; ornithogalum umbellatum whole; picea mariana resin; ruehssia cundurango bark; strychnos nux-vomica seed as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bm Private Limited on January 01, 2015. The current certification is valid through December 31, 2027.

How is this Bm Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85816201202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
85816-2012-2
11-Digit CMS (5-4-2)
85816-2012-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.